Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Targeted Genetics sells assets to Genzyme
Yahoo/AP
Wednesday, September 9, 2009 - 3:14pm
tags:
Targeted Genetics, Genzyme
FDA panel backs Glaxo's cervical vaccine for women
Yahoo/AP
Wednesday, September 9, 2009 - 3:11pm
tags:
GSK, Cervarix, FDA, vaccines, HPV
Sepracor shareholders sue to block deal
Fierce Pharma
Wednesday, September 9, 2009 - 10:45am
tags:
Sepracor, M&A, Dainippon Sumitomo
Red-hot Novavax negotiating vax tech transfers
Fierce Biotech
Wednesday, September 9, 2009 - 9:37am
tags:
Novavax, vaccines
FDA OKs Ista's itchy eye drug
Forbes/AP
Wednesday, September 9, 2009 - 9:35am
tags:
FDA, Ista
[video] One on One with Fred Hassan
CNBC
Wednesday, September 9, 2009 - 9:01am
tags:
Fred Hassan, Schering Plough, Pharma CEOs
FDA weighs US approval of Glaxo's Cervarix, expanded use of Merck's Gardasil to boys
Yahoo/AP
Wednesday, September 9, 2009 - 8:59am
tags:
FDA, GSK, Merck, Gardasil, Cervarix, HPV, vaccines
More Health Care Stocks Primed for Short-Selling: Chanos
CNBC
Wednesday, September 9, 2009 - 8:50am
tags:
AstraZeneca
CytRx to repsond to FDA letter in 4Q
Bizjournals.com
Wednesday, September 9, 2009 - 8:36am
tags:
CytRx, FDA, arimoclomal, ALS
Vivus' obesity drug candidate hits weight reduction goals in 2 late-stage studies; shares soar
Yahoo/AP
Wednesday, September 9, 2009 - 8:27am
tags:
Vivus, obesity, Qnexa
Merck Jury Told to Keep Deliberating in Fosamax Case
Bloomberg
Wednesday, September 9, 2009 - 6:48am
tags:
Merck, lawsuits, osteoporosis, Fosamax
Botox May Get $1 Billion Face Lift as Allergan Migraine Drug
Bloomberg
Wednesday, September 9, 2009 - 6:46am
tags:
Allergan, Botox, migraines
Prices, Profits and the Economics of Big Pharma
Seeking Alpha
Wednesday, September 9, 2009 - 6:45am
tags:
Sanofi, Pfizer, JNJ, GSK, Bayer
Sanofi Grows Strong on Vaccines
Yahoo/Zacks.com
Tuesday, September 8, 2009 - 8:03pm
tags:
Sanofi, vaccines, Baxter International, GSK, AstraZeneca
Cell Therapeutics Fails to Impress
Yahoo/Zacks.com
Tuesday, September 8, 2009 - 8:01pm
tags:
Cell Therapeutics, Biogen Idec, Cephalon, pixantrone
Cornerstone Wins Factive Rights
Yahoo/Zacks.com
Tuesday, September 8, 2009 - 7:57pm
tags:
Cornerstone Therapeutics, Factive, AstraZeneca, GSK, Merck
Pfizer Rep Alleges Viagra Promoted With Unapproved Materials
BNET Pharma
Tuesday, September 8, 2009 - 2:03pm
tags:
Pfizer, Viagra
FDA backs HPV vaccines as panel vote looms
Fierce Biotech
Tuesday, September 8, 2009 - 2:01pm
tags:
FDA, vaccines, HPV, Gardasil, Cervarix, GSK, Merck
Osiris Drug's Failure Was Easy to Envision
TheStreet.com
Tuesday, September 8, 2009 - 1:57pm
tags:
Osiris Therapeutics, Prochymal
Sector Snap: Analyst keeps positive biotech view
Yahoo/AP
Tuesday, September 8, 2009 - 1:57pm
tags:
biotech, Biomarin, Amgen, Genzyme

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.